🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/06/1985 | 0,0212 USD |
| 28/02/1985 | 0,0212 USD |
| 03/12/1984 | 0,0212 USD |
| 31/08/1984 | 0,0199 USD |
| 29/05/1984 | 0,0199 USD |
| 01/03/1984 | 0,0199 USD |
| 29/11/1983 | 0,0199 USD |
| 29/08/1983 | 0,0186 USD |
| 31/05/1983 | 0,0186 USD |
| 28/02/1983 | 0,0186 USD |
| 30/11/1982 | 0,0186 USD |
| 30/08/1982 | 0,0186 USD |
| 01/06/1982 | 0,0186 USD |
| 01/03/1982 | 0,0186 USD |
| 01/12/1981 | 0,0186 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 01/11/2012 | 43,65 | 44,36 | 43,59 | 43,84 | +0,68% | 1,77% | 12.749.968 |
| 31/10/2012 | 44,29 | 44,57 | 43,36 | 43,54 | -1,13% | 2,74% | 14.184.680 |
| 26/10/2012 | 43,69 | 44,63 | 43,69 | 44,04 | -0,32% | 2,14% | 12.513.644 |
| 25/10/2012 | 43,99 | 44,22 | 43,90 | 44,18 | +0,92% | 0,72% | 11.498.132 |
| 24/10/2012 | 43,85 | 44,07 | 43,70 | 43,78 | -0,02% | 0,85% | 10.102.406 |
| 23/10/2012 | 44,07 | 44,40 | 43,77 | 43,79 | -1,27% | 1,43% | 13.104.402 |
| 22/10/2012 | 44,67 | 44,88 | 44,07 | 44,35 | -1,17% | 1,79% | 14.694.427 |
| 19/10/2012 | 45,74 | 45,79 | 44,73 | 44,88 | -1,94% | 2,32% | 13.599.372 |
| 18/10/2012 | 45,12 | 45,80 | 45,11 | 45,76 | +1,20% | 1,52% | 11.513.433 |
| 17/10/2012 | 44,92 | 45,32 | 44,92 | 45,22 | +0,47% | 0,89% | 10.619.279 |
| 16/10/2012 | 44,60 | 45,11 | 44,57 | 45,01 | +1,24% | 1,20% | 12.528.002 |
| 15/10/2012 | 43,65 | 44,49 | 43,60 | 44,46 | +2,13% | 2,06% | 10.774.802 |
| 12/10/2012 | 43,51 | 43,89 | 43,47 | 43,53 | +0,37% | 0,96% | 7.172.826 |
| 11/10/2012 | 43,79 | 43,82 | 43,27 | 43,37 | -0,33% | 1,24% | 7.359.685 |
| 10/10/2012 | 44,06 | 44,27 | 43,32 | 43,51 | -1,23% | 2,14% | 9.930.114 |
| 09/10/2012 | 44,09 | 44,41 | 43,92 | 44,06 | -0,37% | 1,10% | 10.512.383 |
| 08/10/2012 | 44,06 | 44,33 | 43,69 | 44,22 | +0,13% | 1,45% | 7.371.318 |
| 05/10/2012 | 44,29 | 44,37 | 43,76 | 44,16 | +0,35% | 1,38% | 12.463.864 |
| 04/10/2012 | 43,80 | 44,27 | 43,75 | 44,01 | +0,74% | 1,18% | 9.383.582 |
| 03/10/2012 | 43,42 | 43,77 | 43,20 | 43,68 | +0,68% | 1,32% | 8.861.678 |
| 02/10/2012 | 43,35 | 43,51 | 43,03 | 43,39 | +0,55% | 1,10% | 7.786.116 |
| 01/10/2012 | 42,91 | 43,50 | 42,91 | 43,15 | +0,27% | 1,38% | 8.964.278 |
| 28/09/2012 | 42,99 | 43,14 | 42,73 | 43,03 | -0,29% | 0,95% | 13.097.170 |
| 27/09/2012 | 43,01 | 43,36 | 42,95 | 43,16 | +0,49% | 0,95% | 10.306.346 |
| 26/09/2012 | 43,04 | 43,29 | 42,94 | 42,95 | -0,22% | 0,82% | 13.260.134 |
| 25/09/2012 | 43,15 | 43,61 | 42,81 | 43,04 | -0,07% | 1,86% | 13.419.850 |
| 24/09/2012 | 42,89 | 43,18 | 42,74 | 43,07 | +0,51% | 1,02% | 10.468.786 |
| 21/09/2012 | 42,89 | 43,18 | 42,81 | 42,85 | +0,04% | 0,87% | 21.226.821 |
| 20/09/2012 | 42,33 | 42,91 | 42,32 | 42,83 | +0,85% | 1,40% | 10.443.320 |
| 19/09/2012 | 42,10 | 42,73 | 42,07 | 42,47 | +0,98% | 1,56% | 10.289.369 |